- Home
- STIM vs FDMT Comparison
STIM vs FDMT Comparison
Compare STIM & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- FDMT
- Stock Information
- Founded
- STIM 2003
- FDMT 2013
- Country
- STIM United States
- FDMT United States
- Employees
- STIM N/A
- FDMT N/A
- Industry
- STIM Medical/Dental Instruments
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- STIM Health Care
- FDMT Health Care
- Exchange
- STIM Nasdaq
- FDMT Nasdaq
- Market Cap
- STIM 224.8M
- FDMT 192.2M
- IPO Year
- STIM 2018
- FDMT 2020
- Fundamental
- Price
- STIM $3.36
- FDMT $6.46
- Analyst Decision
- STIM Strong Buy
- FDMT Buy
- Analyst Count
- STIM 2
- FDMT 9
- Target Price
- STIM $7.00
- FDMT $30.63
- AVG Volume (30 Days)
- STIM 1.5M
- FDMT 2.6M
- Earning Date
- STIM 08-05-2025
- FDMT 08-11-2025
- Dividend Yield
- STIM N/A
- FDMT N/A
- EPS Growth
- STIM N/A
- FDMT N/A
- EPS
- STIM N/A
- FDMT N/A
- Revenue
- STIM $111,106,000.00
- FDMT $33,000.00
- Revenue This Year
- STIM $105.22
- FDMT $9,921.62
- Revenue Next Year
- STIM $11.89
- FDMT N/A
- P/E Ratio
- STIM N/A
- FDMT N/A
- Revenue Growth
- STIM 54.17
- FDMT N/A
- 52 Week Low
- STIM $0.52
- FDMT $2.24
- 52 Week High
- STIM $5.92
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- STIM 39.34
- FDMT 56.06
- Support Level
- STIM $3.13
- FDMT $6.35
- Resistance Level
- STIM $3.51
- FDMT $7.33
- Average True Range (ATR)
- STIM 0.29
- FDMT 0.56
- MACD
- STIM -0.06
- FDMT -0.06
- Stochastic Oscillator
- STIM 19.49
- FDMT 50.00
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.